Anja Vogt

Cardiology — LMU Klinikum, Germany

LeadR Profile

Anja Vogt LMU Klinikum Germany
350 ScienceLeadR Reputation 350
Network Map

Cardiology

Subspecialties: Endocrinology - Pharmacy - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2003 - 2026

Source: PubMed

Charité - University Medicine Berlin

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 109

Citations

Citations: 2 407 1st author: 10 Last author: 11 Unique author: 19


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network.
heart diseases, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors
Clin Res Cardiol20260
Lipoprotein apheresis in the era of new lipid-lowering therapies.
cholesterol, vldl, lipoproteins, blood component removal, cardiology, cholesterol, therapeutics, lipoprotein(a)
Eur Heart J Top journal20261
Release of rapamycin from core-multishell nanocarriers topically applied on ex vivo human skin probed by scanning transmission X-ray microscopy.
skin, pharmaceutical preparations, sirolimus, microscopy
Eur J Pharm Biopharm20260
Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial.
lipoproteins, blood component removal, cardiology, secondary prevention, odds ratio, therapeutics, lipoprotein(a)
Eur Heart J Top journal20260
Physician and patient perspectives on the treatment of hypercholesterolaemia: a cross-sectional study to identify disconnects.
cross-sectional studies, drug therapy, patient preference, physicians, research, therapeutics
Curr Med Res Opin20250

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 3
N/A 1

By status:

Completed 3
Not yet recruiting 1

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
An open label extension (OLE) trial to evaluate long term safety and tolerability of pelacarsen (TQJ230)
2024-519870-38-00 — safety, cardiovascular diseases
Phase 3Not yet recruiting2026

LeadR Networks

Main global connection map